Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17101841rdf:typepubmed:Citationlld:pubmed
pubmed-article:17101841lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:17101841lifeskim:mentionsumls-concept:C0033384lld:lifeskim
pubmed-article:17101841lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:17101841lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:17101841lifeskim:mentionsumls-concept:C1655807lld:lifeskim
pubmed-article:17101841lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:17101841lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:17101841pubmed:issue1lld:pubmed
pubmed-article:17101841pubmed:dateCreated2006-12-22lld:pubmed
pubmed-article:17101841pubmed:abstractTextProlyl hydroxylase domain 2 protein (PHD2) signals the degradation of hypoxia-inducible factor (HIF)-1alpha by hydroxylating specific prolyl residues located within oxygen-dependent degradation domains. As expected, endothelial cells (ECs) overexpressing PHD2 had reduced HIF-1alpha and vascular endothelial growth factor-A expression and failed to accelerate their proliferation in response to hypoxia. Surprisingly, although these cells displayed further reductions in HIF-1alpha and vascular endothelial growth factor-A expression when cultured under normoxia, there was no further reduction in EC proliferation. Thus, there seemed to be no consistent correlation between PHD2 hydroxylase-mediated suppression of HIF-1alpha expression and inhibition of EC growth. Indeed, overexpression of a mutant PHD2 lacking hydroxylase activity also greatly diminished EC response to hypoxia-induced increase in proliferation, in spite of the fact that hypoxia-induced HIF-1alpha accumulation was not affected by mutant PHD2. These data strongly suggest the existence of a hydroxylase-independent mechanism for PHD2-mediated inhibition of EC proliferation under hypoxia. In support of a physiological relevance of PHD2 overexpression, we found that endogenous PHD2 expression was significantly upregulated by hypoxia and that silencing of the Phd2 gene by RNA interference significantly enhanced hypoxia-induced EC proliferation. In conclusion, this study demonstrates that PHD2 may act as a negative feedback regulator to antagonize hypoxia-induced EC proliferation.lld:pubmed
pubmed-article:17101841pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:languageenglld:pubmed
pubmed-article:17101841pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:citationSubsetIMlld:pubmed
pubmed-article:17101841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17101841pubmed:statusMEDLINElld:pubmed
pubmed-article:17101841pubmed:monthJanlld:pubmed
pubmed-article:17101841pubmed:issn1524-4563lld:pubmed
pubmed-article:17101841pubmed:authorpubmed-author:FongGuo-HuaGHlld:pubmed
pubmed-article:17101841pubmed:authorpubmed-author:TakedaKotaroKlld:pubmed
pubmed-article:17101841pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17101841pubmed:volume49lld:pubmed
pubmed-article:17101841pubmed:ownerNLMlld:pubmed
pubmed-article:17101841pubmed:authorsCompleteYlld:pubmed
pubmed-article:17101841pubmed:pagination178-84lld:pubmed
pubmed-article:17101841pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:meshHeadingpubmed-meshheading:17101841...lld:pubmed
pubmed-article:17101841pubmed:year2007lld:pubmed
pubmed-article:17101841pubmed:articleTitleProlyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.lld:pubmed
pubmed-article:17101841pubmed:affiliationCenter for Vascular Biology, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT 06030-3501, USA.lld:pubmed
pubmed-article:17101841pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17101841pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17101841lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17101841lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17101841lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17101841lld:pubmed